share_log

Cantor Fitzgerald Initiates Coverage On Soleno Therapeutics With Overweight Rating, Announces Price Target of $19

Benzinga ·  Jul 11, 2023 08:38

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Overweight rating and announces Price Target of $19.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment